DashboardPortfoliosWatchlistCommunityDiscoverScreener
  • Community
  • /
  • Japan
  • /
  • Pharmaceuticals & Biotech
Author Program NEWCreate Narrative
7777 logo

3-D Matrix, Ltd. Stock Price

TSE:7777 Community·JP¥44.8b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author
Author Program NEWCreate Narrative

7777 Share Price Performance

JP¥0
-216.00 (-100.00%)
​
JP¥0
-216.00 (-100.00%)
​
Price JP¥0
Thu, 10 Sep 26
Share Pricen/a

7777 Community Narratives

There are no narratives available yet.
Create Narrative
There are no community narratives available.

Trending Discussion

No trending discussion available.

Recently Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet with acceptable track record.

2 Risks
2 Rewards
View Full Analysis

3-D Matrix, Ltd. Key Details

JP¥10.9b

Revenue

JP¥2.3b

Cost of Revenue

JP¥8.6b

Gross Profit

JP¥4.4b

Other Expenses

JP¥4.2b

Earnings

Last Reported Earnings
Apr 30, 2026
Next Reporting Earnings
n/a
32.47
78.74%
38.17%
8.8%
View Full Analysis

About 7777

Founded
2004
Employees
129
CEO
Toshi Amanuma
WebsiteView website
www.3d-matrix.co.jp

3-D Matrix, Ltd. developing, manufacturing, and selling self-assembling peptide technology in Japan and internationally. It offers PuraMatrix, a self-assembling peptide hydrogel for use in the regenerative medicine, cell therapy, drug delivery systems, and other uses in various fields; and surfactant-like peptide, as well as High Concentration PuraMatrix, a high concentration hydrogel; and GMP Grade PuraMatrix. The company was incorporated in 2004 and is based in Tokyo, Japan.

Recent 7777 News & Updates

Analysis Article • Jun 18

3-D Matrix's (TSE:7777) Performance Raises Some Questions

Strong earnings weren't enough to please 3-D Matrix, Ltd.'s ( TSE:7777 ) shareholders over the last week. Our analysis...

Recent updates

No updates

3-D Matrix, Ltd. Competitors

4519 logo

Chugai Pharmaceutical

Symbol: TSE:4519
Market cap: JP¥10.7t
4502 logo

Takeda Pharmaceutical

Symbol: TSE:4502
Market cap: JP¥9.0t
4578 logo

Otsuka Holdings

Symbol: TSE:4578
Market cap: JP¥6.1t
4568 logo

Daiichi Sankyo Company

Symbol: TSE:4568
Market cap: JP¥4.9t
View more competitors

Make Better Investing Decisions Anywhere

Scan to download
Open AppStoreOpen Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
View Data Sources
Markets
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investing Ideas
  • Undervalued Companies
  • Dividend Powerhouses
  • Insider Buying
  • Nuclear Energy
  • Autonomous Vehicles
  • Artificial Intelligence
  • Crypto and Blockchain
  • Cybersecurity
  • More ideas
Stock Communities
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Features & Tools
  • Portfolio Tracker
  • Stock Screener & Alerts
  • Narratives & Fair Values
  • Dividend Calculator
News & Discovery
  • Latest Stock News
  • Global Market Insights
  • The Foxhole
  • Investing Ideas
  • Community Narratives
  • What's New
Simply Wall St
  • Plans & Pricing
  • Advertising
  • About Us
  • Contact Us
  • Careers
  • Help Center
  • Learn Stock Investing
  • Affiliate Program
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Terms and Conditions
  • Privacy Policy
  • AI Terms
  • Financial Services Guide